Covista Inc. (CVSA)
Official siteCONSUMER DEFENSIVE • EDUCATION & TRAINING SERVICES • NYSE
Market Cap: $3.93B
Last updated: Nov 17, 2026 at 4:15 PM ET
Covista Inc. (CVSA) Statistics
Covista (CVSA) has a market cap of $3.93B and an enterprise value of $4.21B. Its share count is down 5.98% from a year earlier.
Total Valuation
Enterprise value is 7.07% above the market cap, as debt exceeds cash.
| Market Cap | $3.93B |
|---|---|
| Enterprise Value | $4.21B |
| Latest price (Nov 17, 2026) | $116.97 |
Key Dates
The next earnings report is expected on Jan 26, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Jan 26, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Fiscal Year End | June |
Valuation Ratios
Sales and book value multiples are 2.0x and 2.8x. Its year-end P/E ranged from 8.4x to 17.1x from 2016 to 2025.
| P/E Ratio | 13.5x |
|---|---|
| Forward P/E | 12.6x |
| P/S Ratio | 2.0x |
| Forward P/S | 1.9x |
| P/B Ratio | 2.8x |
| P/FCF Ratio | 11.2x |
| P/OCF Ratio | 8.7x |
| PEG Ratio | 1.1 |
Enterprise Valuation
Counting debt and cash, the company is valued at 8.7x EBITDA and 12.0x free cash flow.
| EV / Earnings | 16.4x |
|---|---|
| EV / Sales | 2.1x |
| EV / EBITDA | 8.7x |
| EV / EBIT | 10.5x |
| EV / FCF | 12.0x |
Price Statistics
The stock is up 21.26% over 52 weeks and trades 5.90% below its 50-day average.
| Beta (1Y) | 0.27 |
|---|---|
| 52-Week Change | +21.26% |
| 1-Month Change | -9.03% |
| 3-Month Change | -11.34% |
| 6-Month Change | -7.18% |
| 5-Year Change | +236.66% |
| 10-Year Change | +447.71% |
| Total Return (1Y) | +21.26% |
| Total Return (3Y CAGR) | +28.41% |
| Total Return (5Y CAGR) | +30.89% |
| Return vs SPY (1Y) | +10.61% |
| Max Drawdown (1Y) | -23.63% |
| Max Drawdown (3Y) | -42.14% |
| Sharpe Ratio (1Y) | 0.47 |
| Correlation with SPY (1Y) | 0.09 |
| 50-Day Average | $124.31 |
| 200-Day Average | $119.83 |
| 52-Week Range | $86.97 to $142.13 |
| RSI (14 Days) | 40.9 |
| Average Volume (20 Days) | 475.61K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.81x current liabilities, and total debt is 0.35x shareholder equity.
| Current Ratio | 0.81x |
|---|---|
| Quick Ratio | 0.81x |
| Debt / Equity | 0.35x |
| Debt / EBITDA | 1.02x |
| Debt / FCF | 1.41x |
| Interest Coverage | 9.08x |
Returns and Efficiency
Return on invested capital is 16.24% over the last 12 months, against a 5-year average of 12.53%.
| Return on Equity (ROE) | 18.09% |
|---|---|
| Return on Assets (ROA) | 8.78% |
| Return on Invested Capital (ROIC) | 16.24% |
| Return on Capital Employed (ROCE) | 17.92% |
| ROE (5Y Average) | 14.24% |
| ROA (5Y Average) | 7.11% |
| ROIC (5Y Average) | 12.53% |
| Asset Turnover | 0.69x |
Taxes
Income tax took 22.35% of pretax income over the last 12 months.
| Income Tax (TTM) | $79.95M |
|---|---|
| Effective Tax Rate | 22.35% |
Scores
CVSA has an Altman Z-Score of 4.15, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.15 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $2.00B over the last 12 months is up 9.28% from the 12 months before.
| Revenue | $2.00B |
|---|---|
| Revenue Growth (YoY) | +9.28% |
| Gross Profit | $1.15B |
| Operating Income | $395.93M |
| Pretax Income | $357.75M |
| Net Income | $257.16M |
| EBITDA | $491.14M |
| EBIT | $402.03M |
| Reported EPS (TTM) | $8.69 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 48.46% of the $2.93B in total assets.
| Cash and Equivalents | $222.22M |
|---|---|
| Total Debt | $500.23M |
| Net Debt | $278.01M |
| Net Debt Per Share | $8.19 |
| Working Capital | -$131.93M |
| Shareholder Equity | $1.42B |
| Book Value Per Share | $41.87 |
| Tangible Book Value | -$292.48M |
| Total Assets | $2.93B |
| Total Liabilities | $1.51B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $99.27M of capital spending, operating cash flow left $354.65M of free cash flow.
| Operating Cash Flow | $453.91M |
|---|---|
| Capital Expenditures | $99.27M |
| Free Cash Flow | $354.65M |
| FCF Per Share | $10.47 |
| Depreciation and Amortization | $89.11M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 19.76%, against a 5-year average of 13.91%.
| Gross Margin | 57.39% |
|---|---|
| Operating Margin | 19.76% |
| Pretax Margin | 17.86% |
| Net Margin | 12.84% |
| EBITDA Margin | 24.52% |
| EBIT Margin | 20.07% |
| FCF Margin | 17.70% |
| Gross Margin (5Y Average) | 55.53% |
| Operating Margin (5Y Average) | 13.91% |
| Net Margin (5Y Average) | 12.74% |
Growth
Revenue grew 10.44% a year over 3 years, and EPS 25.14% a year.
| Revenue Growth (3Y CAGR) | +10.44% |
|---|---|
| Revenue Growth (5Y CAGR) | +16.79% |
| EPS Growth (3Y CAGR) | +25.14% |
| EPS Growth (5Y CAGR) | +22.67% |
| FCF Growth (3Y CAGR) | +33.27% |
| FCF Growth (5Y CAGR) | +20.86% |
| Operating Income Growth (3Y CAGR) | +31.61% |
Dividends and Yields
CVSA does not pay a dividend. Its free cash flow yield is 8.93%.
| Earnings Yield | 7.41% |
|---|---|
| FCF Yield | 8.93% |
| Buyback Yield | 7.84% |
| Shareholder Yield | 7.84% |
Peer Position
Against 10 similar companies, CVSA has the 6th highest P/E.
P/E RatioPeer median 13.1x
P/S RatioPeer median 1.3x
ROICPeer median 12.92%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +14.37%
| P/E Ratio | 13.5x vs 13.1x median |
|---|---|
| P/S Ratio | 2.0x vs 1.3x median |
| ROIC | 16.24% vs 12.92% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +9.28% vs +14.37% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.76% and EPS growth at 10.69% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.76% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +10.69% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CVSA
What is CVSA's market cap?
Covista has a market cap of $3.93B. Its enterprise value, which adds debt and subtracts cash, is $4.21B.
What is CVSA's P/E ratio?
Covista has a trailing P/E ratio of 13.5x and a forward P/E of 12.6x.
How many shares of CVSA are outstanding?
Covista has 33.95M shares outstanding. The count is down 5.98% from a year earlier.
Does CVSA pay a dividend?
No. Covista does not pay a dividend.
How much debt does CVSA have?
Covista has $500.23M of total debt and $222.22M of cash and equivalents, a net debt position of $278.01M.
CVSA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors